Literature DB >> 10925760

Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high.

H A Leitch1, A Palepu, C M Fernandes.   

Abstract

OBJECTIVE: To update physicians on Group A streptococcal necrotizing fasciitis, including current methods of diagnosis and treatment. QUALITY OF EVIDENCE: Current literature (1990-1998) was searched via MEDLINE using the MeSH headings necrotizing fasciitis, toxic shock syndrome, and Streptococcus. Articles were selected based on clinical relevance and design. Most were case reports, case series, or population-based surveys. There were no randomized controlled trials. MAIN MESSAGE: The hallmark of clinical diagnosis of necrotizing fasciitis is pain out of proportion to physical findings. Suspicion of underlying soft tissue infection should prompt urgent surgical examination. Therapy consists of definitive excisional surgical debridement in conjunction with high-dose intravenous penicillin G and clindamicin. Risk factors for mortality include advanced age, underlying illness, hypotension, and bacteremia.
CONCLUSION: Necrotizing soft tissue infections due to Group A streptococcus might be increasing in frequency and aggression. Overall mortality remains high (20% to 34% in larger series). Clinical diagnosis requires a high level of suspicion and should prompt urgent surgical referral.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925760      PMCID: PMC2144855     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements.

Authors:  J A Riseman; W A Zamboni; A Curtis; D R Graham; H R Konrad; D S Ross
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs.

Authors:  A Rimailho; B Riou; C Richard; P Auzepy
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy.

Authors:  D R Brown; N L Davis; M Lepawsky; J Cunningham; J Kortbeek
Journal:  Am J Surg       Date:  1994-05       Impact factor: 2.565

4.  Hippocrates on necrotising fasciitis.

Authors:  V Descamps; J Aitken; M G Lee
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

5.  Necrotising fasciitis.

Authors:  T S Burge; J D Watson
Journal:  BMJ       Date:  1994-06-04

6.  Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection.

Authors:  D Voros; C Pissiotis; D Georgantas; S Katsaragakis; S Antoniou; J Papadimitriou
Journal:  Br J Surg       Date:  1993-09       Impact factor: 6.939

7.  Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features.

Authors:  J Chelsom; A Halstensen; T Haga; E A Høiby
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

8.  MR imaging in acute infectious cellulitis.

Authors:  A Rahmouni; O Chosidow; D Mathieu; E Gueorguieva; N Jazaerli; C Radier; J M Faivre; J C Roujeau; N Vasile
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

9.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  8 in total

1.  Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs.

Authors:  R P Veenstra; W E Manson; T S van der Werf; J W Fijen; J E Tulleken; J G Zijlstra; J J Ligtenberg
Journal:  Intensive Care Med       Date:  2001-08-15       Impact factor: 17.440

2.  "Emergency" definitive reconstruction of a necrotising fasciitis thigh debridement defect with a pedicled TRAM flap.

Authors:  Tom Hughes; Jonathan T S Yu; Kai Yuen Wong; Charles M Malata
Journal:  Int J Surg Case Rep       Date:  2013-02-24

Review 3.  Laboratory risk indicator for necrotising fasciitis (LRINEC) score for the assessment of early necrotising fasciitis: a systematic review of the literature.

Authors:  J Bechar; S Sepehripour; J Hardwicke; G Filobbos
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

4.  Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study.

Authors:  Lillian S Kao; Debbie F Lew; Samer N Arab; S Rob Todd; Samir S Awad; Matthew M Carrick; Michael G Corneille; Kevin P Lally
Journal:  Am J Surg       Date:  2011-05-04       Impact factor: 2.565

5.  Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection.

Authors:  Felipe A Pinho-Ribeiro; Buket Baddal; Rianne Haarsma; Maghnus O'Seaghdha; Nicole J Yang; Kimbria J Blake; Makayla Portley; Waldiceu A Verri; James B Dale; Michael R Wessels; Isaac M Chiu
Journal:  Cell       Date:  2018-05-10       Impact factor: 41.582

6.  CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection.

Authors:  Hidenori Matsui; Yukie Sekiya; Masahiko Nakamura; Somay Yamagata Murayama; Haruno Yoshida; Tetsufumi Takahashi; Ken'ichi Imanishi; Kanji Tsuchimoto; Takehiko Uchiyama; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

7.  A rare case of Fournier's Gangrene.

Authors:  Sally-Ann Sheehy; Michael E Kelly; Eamon C Francis; Karl J Sweeney; Alan Hussey
Journal:  J Surg Case Rep       Date:  2016-05-05

8.  Predicting Morbidity and Mortality in Patients with Lower Extremity Necrotizing Fasciitis.

Authors:  Fatih İrmak; Semra Karsidag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.